MedTrace Logo

A Comparison of the Efficacy and Safety of HalfLytely Vs Visicol Prior To Colonoscopy.

NCT00164151 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-02-07

No results posted yet for this study

Summary

The objective of this study is to determine the efficacy and safety of HalfLytely as compared to Visicol as bowel preparations before colonoscopic examination.

Conditions

  • Colonoscopy

Interventions

DRUG

HalfLytely

DRUG

Visicol

Sponsors & Collaborators

  • Braintree Laboratories

    lead INDUSTRY

Principal Investigators

  • Charles Brady, MD · University of Texas Health Science Center San Antonio

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-06-30
Primary Completion
2002-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00164151 on ClinicalTrials.gov